Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

VTRS

Viatris (VTRS)

Viatris Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:VTRS
일자시간출처헤드라인심볼기업
2024/05/0920:47IH Market NewsU.S. Index Futures Dip, Bank of England Holds Interest Rates at 5.25%NASDAQ:VTRSViatris Inc
2024/05/0920:44Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTRSViatris Inc
2024/05/0919:59PR Newswire (US)Viatris Reports Strong First Quarter 2024 Financial Results and Reaffirms 2024 Financial Guidance RangesNASDAQ:VTRSViatris Inc
2024/05/0306:00PR Newswire (US)Viatris to Participate in the BofA Securities 2024 Health Care ConferenceNASDAQ:VTRSViatris Inc
2024/05/0119:59PR Newswire (US)Viatris Expands its Wellbeing Program with the Launch of Unmind, a Leading Workplace Resource Focused on Mental HealthNASDAQ:VTRSViatris Inc
2024/04/1705:30PR Newswire (US)Viatris to Report First Quarter 2024 Financial Results on May 9, 2024NASDAQ:VTRSViatris Inc
2024/04/1521:00PR Newswire (US)Viatris Appoints Corinne Le Goff as Chief Commercial OfficerNASDAQ:VTRSViatris Inc
2024/04/1519:59PR Newswire (Canada)Viatris annonce le lancement de la première version générique bioéquivalente du Copaxone [MD] 20 mg/mL au CanadaNASDAQ:VTRSViatris Inc
2024/04/1519:59PR Newswire (Canada)Viatris Announces Launch of First Bioequivalent Generic Version of Copaxone® 20 mg/mL Once-Daily in CanadaNASDAQ:VTRSViatris Inc
2024/04/0119:59PR Newswire (US)Viatris Announces the Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% in the United StatesNASDAQ:VTRSViatris Inc
2024/03/2719:59PR Newswire (US)Viatris Hosts R&D Event Focusing on its Collaboration with Idorsia, Phase 3 Assets Selatogrel and Cenerimod and Key Elements of its PipelineNASDAQ:VTRSViatris Inc
2024/03/0610:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTRSViatris Inc
2024/03/0610:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTRSViatris Inc
2024/03/0610:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTRSViatris Inc
2024/03/0609:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTRSViatris Inc
2024/03/0609:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTRSViatris Inc
2024/03/0609:26Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VTRSViatris Inc
2024/03/0508:11Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VTRSViatris Inc
2024/02/2821:39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTRSViatris Inc
2024/02/2820:30PR Newswire (US)Viatris Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial GuidanceNASDAQ:VTRSViatris Inc
2024/02/2815:00PR Newswire (US)Viatris and Idorsia Enter Into Significant Global Research and Development CollaborationNASDAQ:VTRSViatris Inc
2024/02/2408:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTRSViatris Inc
2024/02/1708:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTRSViatris Inc
2024/02/1607:18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VTRSViatris Inc
2024/02/0520:59PR Newswire (US)Viatris to Announce Fourth Quarter and Full-Year 2023 Financial ResultsNASDAQ:VTRSViatris Inc
2024/01/3106:40Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:VTRSViatris Inc
2024/01/1920:56PR Newswire (US)Viatris recognised as a Top Employer 2024 in the UK for the second consecutive yearNASDAQ:VTRSViatris Inc
2024/01/0608:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTRSViatris Inc
2024/01/0510:28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VTRSViatris Inc
2023/12/2206:05PR Newswire (US)Viatris to Participate in 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:VTRSViatris Inc
 검색 관련기사 보기:NASDAQ:VTRS